Clinical Evaluation: is the assessment and analysis of clinical data pertaining to a medical device in order to verify the clinical safety and performance of the device.
-
MAY 31, 2023 | 10:00 AM
C.E. CREDITS
Date: May 31, 2023 Time: 10:00am (PDT), 1:00pm (EDT), 5:00pm (CEST) Bloodstream infections (BSIs) are defined as a systemic infection resulting from the presence of viable microorganisms in...
MAY 31, 2023 | 6:00 AM
C.E. CREDITS
Although metagenomic next-generation sequencing (mNGS) is increasingly used in clinical microbiological diagnosis, especially for rare or complicated infectious diseases, the applications of...
MAY 25, 2023 | 10:00 AM
C.E. CREDITS
Free light chains, kappa (κ) lambda (λ), are produced by plasma cells and known to be an important marker in patients with Multiple Myeloma and AL Amyloidosis. The precursor con...
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the developme...
MAY 23, 2023 | 7:00 AM
C.E. CREDITS
Fourier Transform Infrared (FTIR) spectroscopy is an emerging technology in the field of microbiology. Recent studies have shown its utility for bacterial typing and the identification of ou...
APR 19, 2023 | 8:00 AM
C.E. CREDITS
Date: April 19, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse...
Date: April 12, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Globally 69 million people worldwide suffer from Traumatic Brain Injury (TBI) every year and many of them are mild and ar...
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
MAR 30, 2023 | 1:50 PM
C.E. CREDITS
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...
Prof. Hofman will present results of a multi-centric study evaluating performance of new Oncomine Dx Express Test, CE IVD for genomic profiling of cancer patient samples. The data cover perf...
MAR 30, 2023 | 1:50 PM
C.E. CREDITS
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms ...
MAR 30, 2023 | 12:25 PM
C.E. CREDITS
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...